IDEAYA Biosciences (IDYA) Non-cash Items (2018 - 2026)

IDEAYA Biosciences has disclosed Non-cash Items across 9 years of filings, most recently posting $6.1 million for Q1 2026.

• Non-cash Items for Q1 2026 came in at $6.1 million, up 56.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.1 million (up 56.27% YoY), and the FY2025 annual result was $5.1 million, down 94.37% from the prior year.
• Non-cash Items came in at $6.1 million for Q1 2026 at IDEAYA Biosciences, down from $136.8 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $136.8 million in Q4 2025 to a low of $2.0 million in Q2 2022.
• The 5-year median for Non-cash Items is $41.1 million (2023), against an average of $53.1 million.
• Across the five-year window, Non-cash Items jumped 67532.85% in 2022 and tumbled 96.32% in 2025, its largest moves.
• IDEAYA Biosciences' Non-cash Items stood at $28.0 million in 2022, then soared by 46.79% to $41.1 million in 2023, then soared by 119.46% to $90.2 million in 2024, then soared by 51.62% to $136.8 million in 2025, then sank by 95.55% to $6.1 million in 2026.
• The last three Non-cash Items figures came in at $6.1 million (Q1 2026), $136.8 million (Q4 2025), and $108.4 million (Q3 2025), per Business Quant data.